2021
DOI: 10.1017/ice.2021.385
|View full text |Cite
|
Sign up to set email alerts
|

A look into the relationship between outdated coronavirus disease 2019 (COVID-19) treatment protocols and the overwhelming rise of mucormycosis in COVID-19 patients in India

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
4
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(4 citation statements)
references
References 8 publications
0
4
0
Order By: Relevance
“…5 Of them had history of frequent use of nebulisers and steam inhalation, which are also suspected to be associated with the rise in mucormycosis, due to the unsterilized equipment used and poor water quality. [16][17][18] In our study, the mean time period of presentation was around 18 days after recovery from covid-19. Some patients even presented after 2-3 months following covid treatment, which necessitates the need of prolonged follow up following covid recovery.…”
Section: Discussionmentioning
confidence: 53%
“…5 Of them had history of frequent use of nebulisers and steam inhalation, which are also suspected to be associated with the rise in mucormycosis, due to the unsterilized equipment used and poor water quality. [16][17][18] In our study, the mean time period of presentation was around 18 days after recovery from covid-19. Some patients even presented after 2-3 months following covid treatment, which necessitates the need of prolonged follow up following covid recovery.…”
Section: Discussionmentioning
confidence: 53%
“…These receptors might facilitate adhesion as well as tissue invasion by mucormycetes, which could aid entry of this pathogen into the nasal sinuses, lungs, and brain. 4,5,7 Statins have been suggested as a treatment to modulate GRP78 receptors and prevent invasive spread of the fungus. The pathophysiology of CNS involvement in mucormycosis was proposed in a report from the Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC) study, 6 which-with 2826 patients-is the largest case series of COVID-19-associated mucormycosis to date.…”
Section: Neurological Infections In 2021: a Spotlight On Indiamentioning
confidence: 99%
“…Analyses of COVID-19 treatment protocols used in India this year 4 , 5 showed that indiscriminate use of corticosteroids, poor control of hyperglycaemia (in people with known or newly diagnosed diabetes), impaired immunity, blanket use of antibiotics, high intake of zinc, prolonged hospital stay, use of industrial oxygen, and ventilators with defective humidifiers were associated with the outbreak of COVID-19-associated mucormycosis. Moreover, COVID-19-related complications, such as cytokine storm, associated hyperglycaemia, and multiorgan dysfunction, have provided a near-perfect acidotic milieu for unabated growth of mucormycetes.…”
mentioning
confidence: 99%
See 1 more Smart Citation